CVS Pharmacy reaches $315M settlement with Justice Department over controlled substance prescriptions
CVS Pharmacy Inc. has agreed to pay $315 million to resolve allegations of illegally filling opioid prescriptions and controlled substances in violation of the Controlled Substances Act. The settlement, announced recently, addresses claims that CVS filled unnecessary prescriptions from 2013 to 2025. The company has strongly disagreed with the case's claims and admitted to no wrongdoing.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ CVS Pharmacy Inc. agreed to pay $315 million to resolve allegations of illegally filling opioid prescriptions.
- ✓ The allegations against CVS include filling unnecessary prescriptions from October 17, 2013, through December 2, 2025.
- ✓ CVS has strongly disagreed with the case's claims and admitted to no wrongdoing.
What changed
The development of a $315 million settlement between CVS Pharmacy and the Justice Department over allegations of illegally filling opioid prescriptions.
Live updates
-
CVS Pharmacy reaches $315M settlement with Justice Department
CVS Pharmacy Inc. has agreed to pay $315 million to resolve allegations of illegally filling opioid prescriptions and controlled substances in violation of the Controlled Substances Act. The settlement, announced recently, addresses claims that CVS filled unnecessary prescriptions from 2013 to 2025. The company has strongly disagreed with the case's claims and admitted to no wrongdoing.
Why it matters
This settlement is part of the federal government's efforts to hold companies accountable for their role in the opioid epidemic. CVS, a major pharmacy chain, has faced allegations of unlawfully dispensing medically unnecessary prescriptions of highly addictive opioids. The case was filed by the government on behalf of a former CVS employee.
What is confirmed
- CVS Pharmacy Inc. agreed to pay $315 million to resolve allegations of illegally filling opioid prescriptions.
- The allegations against CVS include filling unnecessary prescriptions from October 17, 2013, through December 2, 2025.
- CVS has strongly disagreed with the case's claims and admitted to no wrongdoing.
What to watch next
- The implementation details of the settlement and any potential changes to CVS's prescription practices.
- Further actions by the Justice Department against other companies allegedly involved in the opioid epidemic.
- The impact of this settlement on CVS's business operations and reputation.
confidence 90%Sources used for this update (17)
- www.dailymail.com — UK Home | Daily Mail Online
- WSJ — CVS Health Unit to Pay $315 Million to Resolve Illegal Opioid Prescription Claims
- Reuters — CVS to pay $315 million to settle unlawful opioid prescription claims, Justice Department says
- The Hill — CVS to pay $315M settlement over allegations of illegally filling opioid prescriptions
- NBC News — CVS agrees to pay $315 million to settle DOJ opioid prescription case
- Go Local Prov — CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions - Most Violations Took Place Under Foulkes
- Fox Business — CVS Pharmacy reaches $315M settlement with Justice Department over controlled substance prescriptions
- Fierce Healthcare — CVS, DOJ reach $315M settlement in opioid prescription case
- www.foxbusiness.com — CVS Pharmacy reaches $315M settlement with Justice Department over controlled substance prescriptions - F....
- seekingalpha.com — Patient Capital Management Q3 2026 Commentary
- www.marketscreener.com — Global Stocks Fall on Higher Oil Prices, AI Pullback | MarketScreener
- www.foxbusiness.com — Great Business Leaders in America & Around the World | Fox Business
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community